Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1966 1
1971 1
1974 1
1975 1
1977 1
1979 2
1980 1
1981 1
1982 4
1983 4
1984 7
1985 6
1986 8
1987 2
1988 3
1989 3
1990 6
1991 2
1992 9
1993 2
1994 2
1995 1
1997 2
1998 3
1999 5
2000 2
2001 4
2002 7
2003 7
2004 7
2005 4
2006 4
2007 9
2008 3
2009 7
2010 7
2011 14
2012 6
2013 13
2014 5
2015 11
2016 10
2017 19
2018 19
2019 22
2020 34
2021 51
2022 41
2023 26
2024 12

Text availability

Article attribute

Article type

Publication date

Search Results

366 results

Results by year

Filters applied: . Clear all
Page 1
Diabetic Chorea.
Yokozeki K, Nomoto H, Atsumi T. Yokozeki K, et al. Among authors: nomoto h. J Gen Intern Med. 2022 Aug;37(10):2573-2574. doi: 10.1007/s11606-022-07651-w. Epub 2022 May 19. J Gen Intern Med. 2022. PMID: 35590024 Free PMC article. No abstract available.
Improvement of glycaemic control and treatment satisfaction by switching from liraglutide or dulaglutide to subcutaneous semaglutide in patients with type 2 diabetes: A multicentre, prospective, randomized, open-label, parallel-group comparison study (SWITCH-SEMA 1 study).
Takahashi Y, Nomoto H, Yokoyama H, Takano Y, Nagai S, Tsuzuki A, Cho KY, Miya A, Kameda H, Takeuchi J, Taneda S, Kurihara Y, Atsumi T, Nakamura A, Miyoshi H; SWITCH-SEMA 1 study group. Takahashi Y, et al. Among authors: nomoto h. Diabetes Obes Metab. 2023 Jun;25(6):1503-1511. doi: 10.1111/dom.14998. Epub 2023 Feb 28. Diabetes Obes Metab. 2023. PMID: 36722623 Clinical Trial.
Glycaemic control efficacy of switching from dipeptidyl peptidase-4 inhibitors to oral semaglutide in subjects with type 2 diabetes: A multicentre, prospective, randomized, open-label, parallel-group comparison study (SWITCH-SEMA 2 study).
Furusawa S, Nomoto H, Yokoyama H, Suzuki Y, Tsuzuki A, Takahashi K, Miya A, Kameda H, Cho KY, Takeuchi J, Nagai S, Taneda S, Kurihara Y, Nakamura A, Atsumi T; SWITCH-SEMA 2 study group. Furusawa S, et al. Among authors: nomoto h. Diabetes Obes Metab. 2024 Mar;26(3):961-970. doi: 10.1111/dom.15393. Epub 2023 Dec 11. Diabetes Obes Metab. 2024. PMID: 38073422 Clinical Trial.
Ultrafast Simultaneous Raman-Fluorescence Spectroscopy.
Lindley M, Hiramatsu K, Nomoto H, Shibata F, Takeshita T, Kawano S, Goda K. Lindley M, et al. Among authors: nomoto h. Anal Chem. 2019 Dec 17;91(24):15563-15569. doi: 10.1021/acs.analchem.9b03563. Epub 2019 Nov 27. Anal Chem. 2019. PMID: 31774654
OCT Signal Enhancement with Deep Learning.
Lazaridis G, Lorenzi M, Mohamed-Noriega J, Aguilar-Munoa S, Suzuki K, Nomoto H, Ourselin S, Garway-Heath DF; United Kingdom Glaucoma Treatment Study Investigators. Lazaridis G, et al. Among authors: nomoto h. Ophthalmol Glaucoma. 2021 May-Jun;4(3):295-304. doi: 10.1016/j.ogla.2020.10.008. Epub 2020 Oct 15. Ophthalmol Glaucoma. 2021. PMID: 33069883 Clinical Trial.
Cancer prevention by natural compounds.
Tsuda H, Ohshima Y, Nomoto H, Fujita K, Matsuda E, Iigo M, Takasuka N, Moore MA. Tsuda H, et al. Among authors: nomoto h. Drug Metab Pharmacokinet. 2004 Aug;19(4):245-63. doi: 10.2133/dmpk.19.245. Drug Metab Pharmacokinet. 2004. PMID: 15499193 Free article. Review.
A scalable synthesis of (+)-coronafacic acid.
Kato N, Miyagawa S, Nomoto H, Nakayama M, Iwashita M, Ueda M. Kato N, et al. Among authors: nomoto h. Chirality. 2020 Apr;32(4):423-430. doi: 10.1002/chir.23172. Epub 2020 Jan 30. Chirality. 2020. PMID: 31999008
366 results